STOCK TITAN

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for Advanced Health Monitoring and Heatstroke Safety

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that its subsidiary, MEDIROM MOTHER Labs, has begun providing its REMONY remote health monitoring system to the Japan Ground Self-Defense Force (JGSDF). The system features the innovative MOTHER Bracelet®, a recharge-free smart tracker that uses thermoelectric generation technology.

The JGSDF's 8th Division adopted REMONY to address critical health monitoring challenges during extended missions. The system enables continuous health tracking without battery recharging, allowing commanding officers and medical staff to monitor personnel's real-time health conditions and prevent issues like heatstroke in extreme environments.

MEDIROM Healthcare Technologies (NASDAQ: MRM) ha annunciato che la sua controllata, MEDIROM MOTHER Labs, ha iniziato a fornire il sistema REMONY di monitoraggio remoto della salute alle Forze di Autodifesa Terrestri del Giappone (JGSDF). Il sistema presenta l'innovativo MOTHER Bracelet®, un tracker intelligente senza necessità di ricarica che utilizza la tecnologia di generazione termoelettrica.

La 8ª Divisione della JGSDF ha adottato REMONY per affrontare le sfide critiche di monitoraggio della salute durante missioni prolungate. Il sistema consente monitoraggio continuo della salute senza ricarica della batteria, permettendo agli ufficiali e al personale medico di monitorare in tempo reale le condizioni di salute del personale e di prevenire problemi come colpo di calore in ambienti estremi.

MEDIROM Healthcare Technologies (NASDAQ: MRM) anunció que su subsidiaria, MEDIROM MOTHER Labs, ha comenzado a proporcionar su sistema REMONY de monitoreo remoto de la salud a las Fuerzas de Autodefensa de Japón (JGSDF). El sistema cuenta con la innovadora MOTHER Bracelet®, un rastreador inteligente sin necesidad de recarga que utiliza tecnología de generación termoeléctrica.

La 8ª División de la JGSDF adoptó REMONY para abordar los desafíos críticos de monitoreo de la salud durante misiones prolongadas. El sistema permite el seguimiento continuo de la salud sin recargar baterías, permitiendo a los oficiales y al personal médico monitorizar en tiempo real las condiciones de salud del personal y prevenir problemas como golpes de calor en entornos extremos.

MEDIROM Healthcare Technologies (NASDAQ: MRM)이 발표했다. 자회사인 MEDIROM MOTHER Labs가 REMONY 원격 건강 모니터링 시스템을 일본 육상 자위대(JGSDF)에 제공하기 시작했다. 이 시스템은 혁신적인 MOTHER Bracelet®를 특징으로 하며, 재충전이 필요 없는 스마트 트래커로 열전 발전 기술을 사용한다.

JGSDF 제8사단은 장기간 임무 중 건강 모니터링의 중요 도전에 대응하기 위해 REMONY를 채택했다. 이 시스템은 배터리 재충전 없이 연속 건강 추적을 가능하게 하여 지휘관과 의무 직원이 인원들의 건강 상태를 실시간으로 모니터링하고 극한 환경에서 열사병과 같은 문제를 예방할 수 있다.

MEDIROM Healthcare Technologies (NASDAQ : MRM) a annoncé que sa filiale MEDIROM MOTHER Labs a commencé à fournir son système REMONY de surveillance à distance de la santé aux Forces d’autodéfense terrestres japonaises (JGSDF). Le système comprend le MOTHER Bracelet®, un tracker intelligent sans recharge qui utilise la technologie de génération thermoélectrique.

La 8e Division des JGSDF a adopté REMONY pour relever les défis critiques de surveillance de la santé lors de missions prolongées. Le système permet un suivi continu de la santé sans recharge de batterie, permettant aux officiers et au personnel médical de surveiller en temps réel les conditions de santé du personnel et de prévenir des problèmes tels que les coups de chaleur dans des environnements extrêmes.

MEDIROM Healthcare Technologies (NASDAQ: MRM) gab bekannt, dass seine Tochtergesellschaft MEDIROM MOTHER Labs begonnen hat, das REMONY-System zur Fernüberwachung der Gesundheit an die Japan Ground Self-Defense Force (JGSDF) zu liefern. Das System verfügt über das innovative MOTHER Bracelet®, einen wiederaufladungsfreien Smart Tracker, der Thermoelektrik-Technologie verwendet.

Die 8. Division der JGSDF hat REMONY eingeführt, um kritische Gesundheitsüberwachungsherausforderungen während längerer Missionen zu bewältigen. Das System ermöglicht kontinuierliche Gesundheitsverfolgung ohne Batterieladen, sodass Kommandanten und medizinisches Personal den Gesundheitszustand des Personals in Echtzeit überwachen und Probleme wie Hitzeerschöpfung/Hitzeerschlag in extremen Umgebungen verhindern können.

MEDIROM Healthcare Technologies (NASDAQ: MRM) أعلنت أن شركتها الفرعية MEDIROM MOTHER Labs بدأت في توفير نظام REMONY للمراقبة الصحية عن بُعد إلى قوات الدفاع الذاتي اليابانية البرية (JGSDF). يتميز النظام بسوار MOTHER Bracelet® المبتكر، وهو متعقب ذكي لا يحتاج إلى إعادة شحن ويستخدم تقنية التوليد الحراري الكهربائي.

اعتمدت الفرقة الثامنة من JGSDF REMONY لمواجهة التحديات الحرجة في مراقبة الصحة أثناء المهام الطويلة. يتيح النظام تتبّع الصحة باستمرار دون إعادة شحن البطارية، مما يمكّن القادة والكوادر الطبية من مراقبة الحالات الصحية للأفراد في الوقت الفعلي ومنع مشاكل مثل ضربة حرارة في بيئات قاسية.

MEDIROM Healthcare Technologies(NASDAQ: MRM)宣布,其子公司 MEDIROM MOTHER Labs 已开始向日本陆上自卫队(JGSDF)提供 REMONY 远程健康监测系统。该系统具备创新的 MOTHER Bracelet®,一款无需充电的智能追踪器,采用热电发电技术。

JGSDF 第8师团采用 REMONY 以应对长期任务中的关键健康监测挑战。该系统实现了在不需要充电的情况下进行持续健康跟踪,使指挥官和医务人员能够实时监控人员的健康状况,并在极端环境中预防如中暑等问题。

Positive
  • Strategic adoption by a major military organization (JGSDF) demonstrates product validation
  • MOTHER Bracelet's unique thermoelectric technology solves critical battery limitations in remote operations
  • System enables real-time health monitoring and preventive intervention capabilities
Negative
  • None.

Insights

MEDIROM's recharge-free health monitoring system deployment to Japan's military represents significant market validation for their unique thermoelectric technology.

MEDIROM has secured a meaningful deployment for its REMONY remote health monitoring system with the Japan Ground Self-Defense Force (JGSDF) 8th Division. This implementation addresses a critical operational challenge in military settings where conventional wearable devices fail due to recharging limitations.

What makes this technology particularly valuable is the MOTHER Bracelet's thermoelectric generation capability, eliminating the need for recharging during extended missions. This solves a fundamental problem for military personnel operating in remote or harsh environments where power sources are scarce and continuous health monitoring is essential.

The application focuses on real-time health condition monitoring, with special emphasis on heatstroke prevention - a serious concern for military operations that can lead to casualties and mission compromises. By enabling commanders and medical staff to proactively identify health risks before they escalate, the system potentially improves both operational effectiveness and personnel safety.

While financial terms weren't disclosed, this deployment represents significant market validation for MEDIROM's technology. Military contracts often serve as powerful references for additional government and enterprise sales, particularly for solutions addressing critical safety needs. The JGSDF's 8th Division, responsible for southern Kyushu defense and disaster relief, provides a high-profile showcase for REMONY's capabilities under demanding conditions.

The distinguishing factor here is the unique application of thermoelectric technology in wearables - demonstrating MEDIROM's competitive advantage in scenarios where conventional battery-powered devices fail to meet mission-critical requirements.

image6.png

TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has begun providing its remote health monitoring system “REMONY,” powered by the recharge-free smart tracker MOTHER Bracelet®, to the Japan Ground Self-Defense Force (JGSDF).

■Background of the Deployment

In recent years, the importance of health management and heatstroke prevention for personnel operating under extreme conditions has grown significantly. Traditional wearable devices often face limitations in such environments—particularly in mountainous or remote areas where power supply is scarce—making it challenging to collect vital health data or detect anomalies in real-time continuously.

To address these challenges, there has been increasing demand in the field for devices that are lightweight, highly energy-efficient, and capable of long-term use without requiring recharging. In response, the Japan Ground Self-Defense Force 8th Division has adopted “REMONY,” a remote health monitoring system powered by the MOTHER Bracelet®, a recharge-free smart tracker developed by MOTHER Labs.

The MOTHER Bracelet® utilizes thermoelectric generation technology, enabling uninterrupted operation throughout training periods without concerns about battery depletion. This capability was a key factor in its adoption. By leveraging this technology, commanding officers and medical staff can remotely monitor the real-time health conditions of individual personnel during extended missions, allowing them to proactively identify risks such as heatstroke and take preventive measures before health-related issues escalate.

■About the Japan Ground Self-Defense Force 8th Division

The Japan Ground Self-Defense Force 8th Division is responsible for the defense of southern Kyushu and disaster relief operations in the region. The division conducts a wide range of training and missions to ensure the safety and security of local communities.
HP: https://www.mod.go.jp/gsdf/wae/8d

About the MOTHER Bracelet, Recharge-Free Smart Tracker

image1.jpg

MOTHER Bracelet is the world's first* 24/7 recharge-free smart tracker. It uses innovative technology from a Silicon Valley tech company that allows for power generation based on temperature differences between body and surrounding air. The recharge-free feature eliminates the risk of data loss when a device is taken off for recharge. MOTHER Bracelet records five basic metrics: heart rate, calories burned, body surface temperature, step count, and sleep.
Official Website: https://mother-bracelet.com

◾️About REMONY, Remote Health Monitoring System

image5.jpg

REMONY, a remote health monitoring system, developed by MOTHER Labs, combines the wrist-worn recharge-free smart tracker MOTHER Bracelet with a dedicated gateway. The system enables automatic data synchronization and centralized real-time management. Health monitoring with conventional wearables often faces challenges due to data loss during device recharge period. However, MOTHER Bracelet measures user vital data in real-time 24/7 without needing removal for recharge. As a result, it allows prompt and early detection of health emergencies and accident prevention with high accuracy. The system is customizable for use in various industries, including elderly care, health monitoring for night shift workers, etc.

【Features】

  • Measurement and display of heart rate, skin temperature, step count, sleep duration, and calories burned
  • Various alert functions (fall detection, abnormal heart rate, heatstroke, SOS call, etc.)
  • Automatic notification functions linked to alerts

■ABOUT MEDIROM MOTHER Labs Inc.

image4.png

A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), focuses on the health- tech sector. The company’s core activities include the 'Specific Health Guidance Program' offered through the 'Lav' health application and development and sales of the 24/7 recharge-free MOTHER Bracelet smart tracker. By leveraging the features of the recharge-free MOTHER Bracelet, MOTHER Labs offers customizable health management solutions across diverse sectors, including caregiving, logistics, manufacturing, etc.

MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Web: https://medirom.co.jp/en

◼︎MEDIROM Healthcare Technologies Inc.

image3.png

MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Web: https://medirom.co.jp/en
Contact: ir@medirom.co.jp

■Forward-Looking Statements Regarding MEDIROM

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

● MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;

● changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;

● MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;

● the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;

● MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;

● MEDIROM’s ability to raise additional capital on acceptable terms or at all;

● MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;

● changes in consumer preferences and MEDIROM’s competitive environment;

● MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and

● the regulatory environment in which MEDIROM operates.

More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/e8aecd5d-c015-40be-afcc-342d98c2b00b

https://www.globenewswire.com/NewsRoom/AttachmentNg/30a30987-3d7b-4ff9-887d-e9a375138720

https://www.globenewswire.com/NewsRoom/AttachmentNg/691d7a8e-107e-42c2-a5be-c1ced53a097d

https://www.globenewswire.com/NewsRoom/AttachmentNg/ff1f55e1-811a-46a8-8946-01766924e357

https://www.globenewswire.com/NewsRoom/AttachmentNg/c65ac934-5699-489d-a5cf-904c18f41c1a


FAQ

What is MEDIROM's REMONY system being used for by the Japan Ground Self-Defense Force?

REMONY is being used for remote health monitoring and heatstroke prevention of JGSDF personnel during extended missions, utilizing the recharge-free MOTHER Bracelet® smart tracker.

How does MEDIROM (MRM) MOTHER Bracelet® operate without recharging?

The MOTHER Bracelet® uses thermoelectric generation technology that enables continuous operation without requiring battery recharging, making it suitable for extended military missions.

Which division of the Japan Ground Self-Defense Force is implementing MEDIROM's REMONY system?

The JGSDF 8th Division, responsible for southern Kyushu's defense and disaster relief operations, is implementing the REMONY system.

What are the key benefits of MEDIROM's REMONY system for military personnel?

The system enables real-time health monitoring, early detection of health risks like heatstroke, and allows commanding officers to take preventive measures before issues escalate, particularly in extreme conditions.

Why did the JGSDF choose MEDIROM's MOTHER Bracelet® for health monitoring?

The JGSDF selected the MOTHER Bracelet® for its ability to operate continuously without recharging, lightweight design, and capability to monitor health conditions in remote areas where power supply is limited.
Medirom Healthcare Technologies Inc

NASDAQ:MRM

MRM Rankings

MRM Latest News

MRM Latest SEC Filings

MRM Stock Data

11.46M
5.81M
26.42%
1.43%
6.28%
Personal Services
Consumer Cyclical
Link
Japan
Tokyo